Boardroom Alpha
Meeting calendar
IQV · Annual meeting · Thursday, April 23, 2026

Iqvia Holdings Inc

9 nominees · 5 ballot items.

Election of directors; Advisory (non-binding) vote to approve executive compensation (say-on-pay); Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm; Approval of IQVIA Holdings Inc. 2026 Incentive and Stock Award Plan; Stockholder proposal requesting an independent board chairman (opposed by the board).

Market cap
$34.4B
1Y TSR
+12.3%
Board grade
C+
Record date
Feb 23, 2026
Filing
DEF 14A
Meeting concluded · Apr 23, 2026

Follow how the vote landed and what changed on Iqvia Holdings Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot5

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Annual election of nine director nominees to serve one-year terms.

  2. 2

    Advisory Non-Binding Vote on Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding advisory vote to approve named executive officer compensation as disclosed in the proxy statement.

    More detail

    This advisory proposal asks shareholders to approve, on a non-binding basis, the compensation paid to the company’s named executive officers as disclosed in the proxy materials. Management frames the program as pay-for-performance with substantial weight on performance-linked long-term equity and formulaic short-term incentives tied to financial metrics and individual objectives. The LDC Committee recommends a FOR vote, citing alignment with shareholder interests, transparency enhancements based on engagement, and governance safeguards (e.g., clawbacks, share ownership guidelines, and a negative TSR cap). The vote is advisory and won’t bind the Board, but the Board and LDC Committee will consider the result in future compensation decisions. The broader context: prior investor outreach and an 83% prior say-on-pay support in 2025; the company’s compensation program features heavy use of performance shares and SARs, and includes restrictions on repricing and robust recovery provisions.

  3. 3

    Ratification of Appointment of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify PricewaterhouseCoopers LLP as independent registered public accounting firm for 2026.

  4. 4

    Approval of IQVIA Holdings Inc. 2026 Incentive and Stock Award Plan

    ManagementBoard: FOR

    Approve adoption of the 2026 Incentive and Stock Award Plan, authorizing additional shares and replacing the 2017 Plan.

    More detail

    This proposal requests shareholder approval of the 2026 Incentive and Stock Award Plan to replace the 2017 Plan and add 5,750,000 shares to the share reserve (total ~17.94M). The LDC Committee and Board frame the plan as essential to attract, retain and incentivize leadership and employees, aligning pay with shareholder interests via performance-based awards, and have considered burn rate and overhang metrics (recent burn rates 0.66%-1.17%; overhang ~7.5%). Key plan features include a 10-year term, a 1.2M per person annual limit, committee administration, anti-repricing protections, performance-based vesting options, and customary change-in-control provisions. The approval would allow continuation of equity-based compensation; failure would leave the 2017 Plan in place but available shares limited.

  5. 5

    Stockholder Proposal — Independent Board Chairman

    Shareholder — John CheveddenBoard: AGAINST

    Shareholder proposal requesting the Board adopt a policy separating the Chairman and CEO roles and require an independent chairman.

    More detail

    The shareholder proposal, filed by John Chevedden, asks the Board to adopt a formal policy requiring the Chairman and CEO roles be held by separate individuals and that the Chairman be an independent director, arguing separation improves independent oversight and accountability and citing alleged performance and leverage concerns. Management strongly opposes the proposal, disputing factual claims in the proponent’s statement (saying Adjusted EPS beat estimates, net leverage was manageable, and analyst coverage is largely positive) and arguing that mandatory separation removes necessary flexibility. The Board emphasizes its current governance framework—annual election of directors, a Lead Independent Director with clearly defined authorities, fully independent committees, majority voting standard, and recent governance enhancements—and argues that these mechanisms, combined with the Board’s discretion to set leadership structure based on circumstances, already provide robust independent oversight. The matter is a governance/structure proposal reflecting a common stockholder demand alignment debate; management frames it as unnecessary and potentially harmful to flexibility while the proponent frames it as a fix for oversight and accountability.

Director elections

Nominees on the ballot9

Not independent
Tenure on this board
10.2 yrs
Also a director at
Home Depot Inc (HD)
Independent
Tenure on this board
7.4 yrs
Also a director at
Resmed Inc (RMD)
Independent
Tenure on this board
9.8 yrs
Also a director at
Life Time Group Holdings Inc (LTH)
Independent
Tenure on this board
11.5 yrs
Also a director at
Intellia Therapeutics Inc (NTLA)
Independent
Tenure on this board
4.5 yrs
Also a director at
Mfa Financial Inc (MFA)
Ownership

Top institutional holders10

Latest 13F quarter
1HARRIS ASSOCIATES L P7.2%11,988,557$2.0B
2VANGUARD CAPITAL MANAGEMENT LLC6.6%11,026,983$1.9B
3VANGUARD PORTFOLIO MANAGEMENT LLC4.5%7,576,001$1.3B
4STATE STREET CORP4.5%7,476,962$1.3B
5BlackRock, Inc.3.2%5,300,033$904M
6Artisan Partners Limited Partnership3.0%5,058,865$863M
7JPMORGAN CHASE CO2.6%4,321,869$718M
8GEODE CAPITAL MANAGEMENT, LLC2.3%3,918,235$665M
9BlackRock, Inc.2.1%3,451,326$589M
10Boston Partners1.9%3,130,517$534M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Iqvia Holdings Inc 2026 annual meeting?
Iqvia Holdings Inc (IQV) holds its 2026 annual shareholder meeting on Thursday, April 23, 2026.
What is the record date for the Iqvia Holdings Inc 2026 meeting?
The record date for the Iqvia Holdings Inc 2026 meeting is Monday, February 23, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Iqvia Holdings Inc's 2026 meeting?
The board is presenting 9 director nominees at the Iqvia Holdings Inc 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Iqvia Holdings Inc 2026 meeting?
Shareholders will vote on 5 proposals at the Iqvia Holdings Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer